Tissue | Expression Dynamics | Abbreviation |
Breast | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Breast/GSTP1_pca_on_diff_genes.png) | IDC: Invasive ductal carcinoma |
DCIS: Ductal carcinoma in situ |
Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers |
Cervix | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Cervix/GSTP1_pca_on_diff_genes.png) | CC: Cervix cancer |
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions |
N_HPV: HPV-infected normal cervix |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/GSTP1_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/GSTP1_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/GSTP1_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/GSTP1_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/GSTP1_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/GSTP1_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/GSTP1_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/GSTP1_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/GSTP1_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/GSTP1_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001056323 | Lung | AAH | negative regulation of phosphorus metabolic process | 28/613 | 442/18723 | 7.12e-04 | 2.55e-02 | 28 |
GO:190165322 | Lung | AAH | cellular response to peptide | 24/613 | 359/18723 | 8.02e-04 | 2.72e-02 | 24 |
GO:004340922 | Lung | AAH | negative regulation of MAPK cascade | 15/613 | 180/18723 | 8.78e-04 | 2.88e-02 | 15 |
GO:005140323 | Lung | AAH | stress-activated MAPK cascade | 18/613 | 239/18723 | 9.29e-04 | 2.92e-02 | 18 |
GO:003286822 | Lung | AAH | response to insulin | 19/613 | 264/18723 | 1.17e-03 | 3.33e-02 | 19 |
GO:200123423 | Lung | AAH | negative regulation of apoptotic signaling pathway | 17/613 | 224/18723 | 1.17e-03 | 3.33e-02 | 17 |
GO:00706635 | Lung | AAH | regulation of leukocyte proliferation | 18/613 | 245/18723 | 1.23e-03 | 3.40e-02 | 18 |
GO:007137522 | Lung | AAH | cellular response to peptide hormone stimulus | 20/613 | 290/18723 | 1.47e-03 | 3.76e-02 | 20 |
GO:000974323 | Lung | AAH | response to carbohydrate | 18/613 | 253/18723 | 1.76e-03 | 4.22e-02 | 18 |
GO:00706615 | Lung | AAH | leukocyte proliferation | 21/613 | 318/18723 | 1.93e-03 | 4.37e-02 | 21 |
GO:007030223 | Lung | AAH | regulation of stress-activated protein kinase signaling cascade | 15/613 | 195/18723 | 1.96e-03 | 4.39e-02 | 15 |
GO:004232623 | Lung | AAH | negative regulation of phosphorylation | 24/613 | 385/18723 | 2.06e-03 | 4.56e-02 | 24 |
GO:000193323 | Lung | AAH | negative regulation of protein phosphorylation | 22/613 | 342/18723 | 2.11e-03 | 4.61e-02 | 22 |
GO:007136421 | Lung | MIAC | cellular response to epidermal growth factor stimulus | 11/967 | 45/18723 | 1.32e-05 | 9.85e-04 | 11 |
GO:200123333 | Lung | MIAC | regulation of apoptotic signaling pathway | 38/967 | 356/18723 | 1.88e-05 | 1.27e-03 | 38 |
GO:007084921 | Lung | MIAC | response to epidermal growth factor | 11/967 | 49/18723 | 3.15e-05 | 1.86e-03 | 11 |
GO:007138323 | Lung | MIAC | cellular response to steroid hormone stimulus | 25/967 | 204/18723 | 5.46e-05 | 2.75e-03 | 25 |
GO:000697923 | Lung | MIAC | response to oxidative stress | 43/967 | 446/18723 | 6.39e-05 | 3.12e-03 | 43 |
GO:000974332 | Lung | MIAC | response to carbohydrate | 28/967 | 253/18723 | 1.23e-04 | 5.10e-03 | 28 |
GO:004854523 | Lung | MIAC | response to steroid hormone | 34/967 | 339/18723 | 1.73e-04 | 6.42e-03 | 34 |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0541818 | Breast | Precancer | Fluid shear stress and atherosclerosis | 28/684 | 139/8465 | 4.74e-06 | 6.00e-05 | 4.59e-05 | 28 |
hsa0048010 | Breast | Precancer | Glutathione metabolism | 12/684 | 57/8465 | 1.68e-03 | 1.08e-02 | 8.30e-03 | 12 |
hsa0541819 | Breast | Precancer | Fluid shear stress and atherosclerosis | 28/684 | 139/8465 | 4.74e-06 | 6.00e-05 | 4.59e-05 | 28 |
hsa0048013 | Breast | Precancer | Glutathione metabolism | 12/684 | 57/8465 | 1.68e-03 | 1.08e-02 | 8.30e-03 | 12 |
hsa0541824 | Breast | IDC | Fluid shear stress and atherosclerosis | 34/867 | 139/8465 | 9.41e-07 | 1.61e-05 | 1.20e-05 | 34 |
hsa0048023 | Breast | IDC | Glutathione metabolism | 13/867 | 57/8465 | 4.25e-03 | 2.56e-02 | 1.91e-02 | 13 |
hsa0541834 | Breast | IDC | Fluid shear stress and atherosclerosis | 34/867 | 139/8465 | 9.41e-07 | 1.61e-05 | 1.20e-05 | 34 |
hsa0048033 | Breast | IDC | Glutathione metabolism | 13/867 | 57/8465 | 4.25e-03 | 2.56e-02 | 1.91e-02 | 13 |
hsa0541844 | Breast | DCIS | Fluid shear stress and atherosclerosis | 34/846 | 139/8465 | 5.31e-07 | 9.03e-06 | 6.65e-06 | 34 |
hsa0048041 | Breast | DCIS | Glutathione metabolism | 13/846 | 57/8465 | 3.44e-03 | 1.98e-02 | 1.46e-02 | 13 |
hsa0541854 | Breast | DCIS | Fluid shear stress and atherosclerosis | 34/846 | 139/8465 | 5.31e-07 | 9.03e-06 | 6.65e-06 | 34 |
hsa0048051 | Breast | DCIS | Glutathione metabolism | 13/846 | 57/8465 | 3.44e-03 | 1.98e-02 | 1.46e-02 | 13 |
hsa0541820 | Cervix | CC | Fluid shear stress and atherosclerosis | 50/1267 | 139/8465 | 5.71e-10 | 1.32e-08 | 7.81e-09 | 50 |
hsa052157 | Cervix | CC | Prostate cancer | 27/1267 | 97/8465 | 7.54e-04 | 3.39e-03 | 2.01e-03 | 27 |
hsa0522510 | Cervix | CC | Hepatocellular carcinoma | 40/1267 | 168/8465 | 1.52e-03 | 6.39e-03 | 3.78e-03 | 40 |
hsa05418110 | Cervix | CC | Fluid shear stress and atherosclerosis | 50/1267 | 139/8465 | 5.71e-10 | 1.32e-08 | 7.81e-09 | 50 |
hsa0521512 | Cervix | CC | Prostate cancer | 27/1267 | 97/8465 | 7.54e-04 | 3.39e-03 | 2.01e-03 | 27 |
hsa0522513 | Cervix | CC | Hepatocellular carcinoma | 40/1267 | 168/8465 | 1.52e-03 | 6.39e-03 | 3.78e-03 | 40 |
hsa05418 | Colorectum | AD | Fluid shear stress and atherosclerosis | 54/2092 | 139/8465 | 1.41e-04 | 1.16e-03 | 7.37e-04 | 54 |
hsa05225 | Colorectum | AD | Hepatocellular carcinoma | 59/2092 | 168/8465 | 1.50e-03 | 8.69e-03 | 5.54e-03 | 59 |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | DNR | | 10050715 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | FOLFOX REGIMEN | | 19922504 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | NITROGEN MUSTARD | | 2882834 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | ADM | | 9382956 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | thiotepa | THIOTEPA | |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | PREDNISONE | PREDNISONE | 11186134 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | CARBOPLATIN | CARBOPLATIN | 12360105 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | epirubicin | EPIRUBICIN | 25008867,21362365,20568049 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | 5-AZACYTIDINE | AZACITIDINE | 11696442 |
2950 | GSTP1 | ENZYME, CLINICALLY ACTIONABLE, DRUGGABLE GENOME | | fluorouracil | FLUOROURACIL | 27995989,21449681,18540691 |